Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for perioperative hypothermia in video-assisted thoracoscopic surgery
KCT0009497Phase 4Completed
- Sponsor
- Hana Pharm
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in None (2 arms), sponsored by Hana Pharm. Primary endpoint: Incidence and degree of perioperative hypothermia. Started Mar 2025; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on KCT0009497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009497.